[Bone metastasis from gastrinoma without hepatic involvement. Utility of the scintigraphy with 111 In-pentetreotide]

Rev Esp Med Nucl. 2001 Feb;20(1):23-6.
[Article in Spanish]

Abstract

The case of a 54 year old patient suffering from gastrinoma (within a type I multiple endocrine neoplasm) is presented. In 1990, she underwent a surgical resection. Eight years later, she suffered from a pain in the left thigh. The 99mTc-MDP bone scintigraphy showed bone metastasis. The CT scan did not show any hepatic involvement and the scintigraphy with 111In-Pentetreotide verified bone metastasis of a neuroendocrine tumor as a single expression of the recidive. In this case, the utility of the scintigraphy with octreotide to facilitate the localization and extent of the neuroendocrine tumors is demonstrated.

Publication types

  • Case Reports

MeSH terms

  • Adrenalectomy
  • Female
  • Femoral Neoplasms / diagnostic imaging
  • Femoral Neoplasms / radiotherapy
  • Femoral Neoplasms / secondary*
  • Gastrinoma / complications
  • Gastrinoma / diagnostic imaging
  • Gastrinoma / radiotherapy
  • Gastrinoma / secondary*
  • Humans
  • Hyperparathyroidism, Secondary / etiology
  • Liver / diagnostic imaging
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 / diagnostic imaging*
  • Palliative Care
  • Pancreatectomy
  • Pancreatic Neoplasms / complications
  • Pancreatic Neoplasms / pathology*
  • Pancreatic Neoplasms / surgery
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Somatostatin / analogs & derivatives*
  • Splenectomy
  • Zollinger-Ellison Syndrome / etiology

Substances

  • Radiopharmaceuticals
  • Somatostatin
  • pentetreotide